#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ewing's sarcoma recurrent Neovascular age-related macular degeneration Infantile apnoea Necrotising myositis Astrocytoma Plasma cell myeloma recurrent Fusarium infection Hypersensitivity pneumonitis Colon cancer Glomerulonephritis rapidly progressive Biliary cancer metastatic Idiopathic pulmonary fibrosis Loss of consciousness Breast cancer metastatic Homocystinuria More trials…

    Learn about Rare Diseases

    Andersen-Tawil syndrome – Basic Information Mucopolysaccharidosis I – Treatment Ocular melanoma – Diagnostics Gaucher’s disease type I – Trials in Disease Hairy cell leukaemia Mucopolysaccharidosis II – Diagnostics Pemphigus – Basic Information Synovial sarcoma recurrent – Trials in Disease Haemophagocytic lymphohistiocytosis – Basic Information Leiomyosarcoma recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Donidalorsen NORELGESTROMIN Estriol Chlorhexidine Dihydrochloride Glepaglutide Timolol Maleate Luspatercept Gadoxetic Acid, Disodium Clopidogrel Hydrogen Sulfate Crovalimab Timolol Calcium Oxybate Povidone Colchicine Asfotase Alfa Timbetasin Acetate Carfilzomib Gsk3858279 ULTEVURSEN Ecoo2 More therapies…

    Learn about Your Condition

    Herpes simplex meningitis Breast cancer metastatic Testis cancer Myeloid leukaemia Urethral stenosis Breast conserving surgery Labour induction Asymptomatic HIV infection Apheresis Glaucoma Mantle cell lymphoma stage III EGFR gene mutation Cardiac arrest Stem cell transplant Lichen sclerosus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopitaux Universitaires Pitie Salpetriere

Hopitaux Universitaires Pitie Salpetriere

47 Boulevard De L Hopital, Paris, 75651, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Rituximab compared to placebo in patients with anti-MAG neuropathy who are likely to respond well to treatment

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Anti-myelin-associated glycoprotein associated polyneuropathy
    Investigated Drugs:
    • Rituximab
    • Sodium Chloride
    France

  • Study on Apremilast for Patients with Severe Recurrent Mouth Ulcers Resistant to Colchicine

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Stomatitis
    Investigated Drugs:
    • Apremilast
    France

  • Study of Cannabidiol for Treatment of Recurrent Pericarditis in Affected Patients

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Pericarditis
    Investigated Drugs:
    • Cannabidiol
    France

  • Safety and tolerability of intrathecal S233107 in participants with spinocerebellar ataxia type 3: a Phase 1b/2a first‑in‑human randomized study

    Not recruiting

    2 1
    Denmark France Portugal Spain

  • A Study to Test the Long-term Safety and Benefits of GSK4527226 in Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Gsk4527226
    Finland France Germany Italy The Netherlands Norway +2

  • Study of cisplatin, gemcitabine and rilvegostomig treatment in patients with high-risk resectable intrahepatic cholangiocarcinoma

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Cisplatin
    • Gemcitabine
    • Rilvegostomig
    France

  • Study of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)

    Not recruiting

    3 1
    Investigated Diseases:
    • Type IIa hyperlipidaemia
    Bulgaria Czechia Denmark Finland France Germany +6

  • Evaluating Sonrotoclax Alone and Combined with Zanubrutinib for Patients with Previously Untreated or Relapsed/Refractory Waldenström Macroglobulinemia

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Waldenstrom’s macroglobulinaemia
    • Waldenstrom’s macroglobulinaemia refractory
    Investigated Drugs:
    • Zanubrutinib
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    France Greece Italy Spain

  • Long-Term Safety Study of Plozasiran for Adults with High Triglycerides

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypertriglyceridaemia
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Belgium Bulgaria Croatia Czechia France Germany +8

  • Study on the Effects of Maplirpacept, Glofitamab, and Obinutuzumab in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma Not Eligible for Stem Cell Transplant

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • MAPLIRPACEPT
    • Glofitamab
    • Obinutuzumab
    France Germany Spain
Previous Page
1 … 9 10 11 12 13 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!